 Progression survival studies early chronic lymphocytic leukemia natural history stage chronic lymphocytic leukemia CLL patients cases evaluable disease progression advanced clinical stages actuarial estimation event years CI linear trend risk hazard function analysis constant pattern progression lack correlation event time disease progression time-dependent variable clear-cut impact survival aim subgroup patients low probability disease progression death set patients different proposals stage methods similar terms sample size survival rate disease progression risk choice different proposals arbitrary criteria CLL patients present study overall series stage patients progression occurs